| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Zerhouni Elias A. | Director | 2200 PENNSYLVANIA AVENUE, NW, SUITE 800W, WASHINGTON | /s/ James F. O'Reilly, attorney-in-fact for Elias A. Zerhouni, M.D. | 03 Nov 2025 | 0001478398 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DHR | Phantom shares | Award | $43.8K | +203 | +1.14% | $215.38 | 18K | 31 Oct 2025 | Common Stock | 203 | $0.00 | Direct | F1, F2, F3 |
| Id | Content |
|---|---|
| F1 | Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. |
| F2 | Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis. |
| F3 | The reporting person is fully vested in all amounts deferred under the Plan. |